Cc1ccc(-c2n[nH]c(SCC(=O)c3c(N)n(C4CC4)c(=O)[nH]c3=O)n2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?